Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use

被引：110

作者：

Mavrogeni, Sophie I. ^{[1
]}

Kitas, George D. ^{[2
]}

Dimitroulas, Theodoros ^{[3
]}

Sfikakis, Petros P. ^{[4
]}

Seo, Philip ^{[5
]}

Gabriel, Sherine ^{[6
]}

Patel, Amit R. ^{[7
]}

Gargani, Luna ^{[8
]}

Bombardieri, Stefano ^{[9
]}

Matucci-Cerinic, Marco ^{[10
]}

Lombardi, Massimo ^{[11
]}

Pepe, Alessia ^{[12
]}

Aletras, Anthony H. ^{[13
]}

Kolovou, Genovefa ^{[1
]}

Miszalski, Tomasz ^{[14
,15
,16
]}

van Riel, Piet ^{[17
]}

Semb, AnneGrete ^{[18
]}

Angel Gonzalez-Gay, Miguel ^{[19
]}

Dessein, Patrick ^{[20
]}

Karpouzas, George ^{[21
]}

Puntmann, Valentina ^{[22
]}

Nagel, Eike ^{[22
]}

Bratis, Konstantinos ^{[23
]}

Karabela, Georgia ^{[24
]}

Stavropoulos, Efthymios ^{[24
]}

Katsifis, Gikas ^{[24
]}

Koutsogeorgopoulou, Loukia ^{[25
]}

van Rossum, Albert ^{[26
]}

Rademakers, Frank ^{[27
]}

Pohost, Gerald ^{[28
]}

Lima, Joao A. C. ^{[29
]}

机构：

[1] Onassis Cardiac Surg Ctr, Athens, Greece

[2] Univ Manchester, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England

[3] Russells Hall Hosp, Dudley Grp NHS Fdn Trust, Dept Rheumatol, Dudley DY1 2LT, W Midlands, England

[4] Univ Athens, Sch Med, Laikon Hosp, Dept Propeudeut & Internal Med 1, GR-11527 Athens, Greece

[5] Johns Hopkins Univ Hosp, Dept Rheumatol, Baltimore, MD 21287 USA

[6] Mayo Clin, Dept Med Rheumatol & Epidemiol, Rochester, MN USA

[7] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA

[8] CNR, Inst Clin Physiol, I-56100 Pisa, Italy

[9] Univ Pisa, Dept Clin & Expt Med, Div Rheumatol, Pisa, Italy

[10] Univ Florence, Azienda Osped Univ Careggi, Div Internal Med & Rheumatol, Expt & Clin Med, Florence, Italy

[11] Policlin San Donato, Multimodal Cardiac Imaging Sect, Milan, Italy

[12] Fdn G Monasterio CNR, Magnet Resonance Imaging Unit, Pisa, Italy

[13] Univ Thessaloniki, Dept Med, Lab Comp & Med Informat, GR-54006 Thessaloniki, Greece

[14] Jagiellonian Univ, Coll Med, Dept Internal Med, Krakow, Poland

[15] John Paul 2 Hosp, Ctr Diag Prevent & Telemed, Krakow, Poland

[16] 4th Mil Hosp, Dept Clin Radiol & Imaging Diagnost, Wroclaw, Poland

[17] Radbound Univ, Med Ctr, Dept Rheumatol, Radbound, Netherlands

[18] Diakonhjemmet Hosp, Dept Rheumatol, Prevent Cardiorheuma clin, Oslo, Norway

[19] Clin Univ Hosp Santiago De Compostela, Hlth Res Inst Santiago De Compostela IDIS, Div Rheumatol, Santiago De Compostela, Spain

[20] Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Cardiovasc Pathophysioloy & Genom Res Unit, Johannesburg, South Africa

[21] Div Rheumatol, London, England

[22] Univ Hosp Frankfurt, Frankfurt, Germany

[23] Kings Coll London, London WC2R 2LS, England

[24] Athens Naval Hosp, Athens, Greece

[25] Univ Athens, Sch Med, Dept Pathophysiol, GR-11527 Athens, Greece

[26] Vrije Univ Amsterdam, Med Ctr, Dept Cardiol, Amsterdam, Netherlands

[27] Univ Hosp Leuven, Dept Cardiol, Leuven, Belgium

[28] Univ So Calif, Dept Cardiol, Los Angeles, CA 90089 USA

[29] Johns Hopkins Univ, Dept Med Radiol & Epidemiol, Baltimore, MD USA

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2016年 / 217卷

关键词：

Rheumatic diseases; Cardiovascular magnetic resonance imaging; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CORONARY-ARTERY-DISEASE; EMISSION COMPUTED-TOMOGRAPHY; SUBCLINICAL MYOCARDIAL INFLAMMATION; WALL-MOTION ABNORMALITIES; VENTRICULAR MASS INDEX; COLLEGE-OF-CARDIOLOGY; HEART-FAILURE; CARDIAC INVOLVEMENT; EMERGING ROLE;

D O I：

10.1016/j.ijcard.2016.04.158

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Targeted therapies in connective tissue diseases (CTDs) have led to improvements of disease-associated outcomes, but life expectancy remains lower compared to general population due to emerging co-morbidities, particularly due to excess cardiovascular risk. Cardiovascular magnetic resonance (CMR) is a noninvasive imaging technique which can provide detailed information about multiple cardiovascular pathologies without using ionizing radiation. CMR is considered the reference standard for quantitative evaluation of left and right ventricular volumes, mass and function, cardiac tissue characterization and assessment of thoracic vessels; it may also be used for the quantitative assessment of myocardial blood flow with high spatial resolution and for the evaluation of the proximal coronary arteries. These applications are of particular interest in CTDs, because of the potential of serious and variable involvement of the cardiovascular system during their course. The International Consensus Group on CMR in Rheumatology was formed in January 2012 aiming to achieve consensus among CMR and rheumatology experts in developing initial recommendations on the current state-of-the-art use of CMR in CTDs. The present report outlines the recommendations of the participating CMR and rheumatology experts with regards to: (a) indications for use of CMR in rheumatoid arthritis, the spondyloarthropathies, systemic lupus erythematosus, vasculitis of small, medium and large vessels, myositis, sarcoidosis (SRC), and scleroderma (SSc); (b) CMR protocols, terminology for reporting CMR and diagnostic CMR criteria for assessment and quantification of cardiovascular involvement in CTDs; and (c) a research agenda for the further development of this evolving field. (C) 2016 Elsevier Ireland Ltd. All rights reserved.

引用

页码：135 / 148

页数：14

共 209 条

[1] Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction [J].